B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 5.76 HKD -3.84%
Market Cap: 2.3B HKD
Have any thoughts about
Biocytogen Pharmaceuticals Beijing Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Biocytogen Pharmaceuticals Beijing Co Ltd

Wall Street analysts forecast Biocytogen Pharmaceuticals Beijing Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Biocytogen Pharmaceuticals Beijing Co Ltd is 15.17 HKD with a low forecast of 13.62 HKD and a high forecast of 17.06 HKD.

Lowest
Price Target
13.62 HKD
137% Upside
Average
Price Target
15.17 HKD
163% Upside
Highest
Price Target
17.06 HKD
196% Upside
Biocytogen Pharmaceuticals Beijing Co Ltd Competitors:
Price Targets
KZR
Kezar Life Sciences Inc
238% Upside
084650
Labgenomics Co Ltd
83% Upside
9926
Akeso Inc
6% Upside
145020
Hugel Inc
20% Upside
SGMO
Sangamo Therapeutics Inc
59% Upside
214450
PharmaResearch Co Ltd
24% Upside
LEGN
Legend Biotech Corp
115% Upside
DVYSR
Devyser Diagnostics AB
11% Upside

Revenue
Forecast

Revenue Estimate
Biocytogen Pharmaceuticals Beijing Co Ltd

For the last 2 years the compound annual growth rate for Biocytogen Pharmaceuticals Beijing Co Ltd's revenue is 42%. The projected CAGR for the next 3 years is 26%.

42%
Past Growth
26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Biocytogen Pharmaceuticals Beijing Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Biocytogen Pharmaceuticals Beijing Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Biocytogen Pharmaceuticals Beijing Co Ltd's stock price target?
Price Target
15.17 HKD

According to Wall Street analysts, the average 1-year price target for Biocytogen Pharmaceuticals Beijing Co Ltd is 15.17 HKD with a low forecast of 13.62 HKD and a high forecast of 17.06 HKD.

What is Biocytogen Pharmaceuticals Beijing Co Ltd's Revenue forecast?
Projected CAGR
26%

For the last 2 years the compound annual growth rate for Biocytogen Pharmaceuticals Beijing Co Ltd's revenue is 42%. The projected CAGR for the next 3 years is 26%.

Back to Top